Pfizer says COVID-19 pill cut hospital death risk by 90%
By [email protected] Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication […]
Debe estar conectado para enviar un comentario.